COM:AERIEPHARMA
Aerie Pharmaceuticals, Inc.
- Stock
Last Close
15.25
18/11 21:00
Volume Today
1.22M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.08 - | 0.15 82.02% | 0.21 33.92% | 0.45 117.62% | ||||||
cash conversion cycle | -1.26K - | 825.94 165.37% | 508.66 38.41% | 735.39 44.58% | ||||||
cash per share | 14.05 - | 5.81 58.67% | 5.30 8.82% | 8.02 51.40% | 7.07 11.87% | 4.87 31.12% | 6.81 39.82% | 5.24 23.06% | 3.02 42.39% | |
company equity multiplier | 1.05 - | 5.74 446.05% | 8.48 47.54% | 2.36 72.20% | 2.14 9.16% | 1.25 41.55% | 2.71 116.67% | 16.77 518.74% | -24.89 248.37% | |
days of inventory outstanding | 5.76K - | 1.59K 72.39% | 389.87 75.48% | 549.42 40.92% | ||||||
days of payables outstanding | 7.06K - | 964.42 86.34% | 127.17 86.81% | 112.64 11.42% | ||||||
days of sales outstanding | 40.98 - | 200.31 388.78% | 245.95 22.79% | 298.62 21.41% | ||||||
dividend yield | ||||||||||
ebit per revenue | -8.67 - | -2.68 69.07% | -1.87 30.20% | -0.24 87.25% | ||||||
ebt per ebit | 1.40 - | 0.96 31.44% | 0.99 2.63% | 1.02 3.24% | 1.01 1.23% | 1.11 10.00% | 1.06 3.96% | 1.14 7.27% | 1.60 40.15% | |
effective tax rate | -0.00 - | -0.00 4.24% | 0.01 713.19% | -0.00 100.11% | 0.00 3,594.24% | -0.03 6,642.59% | -0.01 72.91% | |||
enterprise value multiple | -0.71 - | -15.64 2,104.42% | -9.23 40.95% | -10.78 16.80% | -14.24 32.00% | -5.72 59.84% | -6.90 20.76% | -5.83 15.51% | -70.23 1,104.00% | |
fixed asset turnover | 0.40 - | 1.20 200.84% | 1.22 1.21% | 2.62 115.25% | ||||||
free cash flow per share | -3.33 - | -1.41 57.75% | -2.29 62.64% | -2.91 27.30% | -3.09 6.05% | -4.41 42.80% | -3.53 20.01% | -1.48 58.17% | -2.21 49.69% | |
gross profit margin | 0.97 - | 0.93 4.38% | 0.70 25.31% | 0.86 23.94% | ||||||
interest coverage | -5.84 - | -79.57 1,262.11% | -30.12 62.15% | -38.18 26.78% | -61.53 61.13% | -82.87 34.69% | -12.29 85.17% | -5.88 52.15% | -1.60 72.73% | |
inventory turnover | 0.06 - | 0.23 262.13% | 0.94 307.84% | 0.66 29.04% | ||||||
long term debt to capitalization | 0.82 - | 0.87 6.38% | 0.54 37.80% | 0.48 11.56% | 0.53 - | 0.90 69.22% | 1.07 19.47% | |||
net income per ebt | 1 - | 1 0% | 1.00 0.19% | 1.00 0.01% | 0.99 1.39% | 1.00 1.21% | 1.00 0.05% | 1.03 3.00% | 1.01 2.09% | |
net profit margin | -9.62 - | -2.86 70.31% | -2.20 22.88% | -0.39 82.50% | ||||||
operating cash flow per share | -3.32 - | -1.40 57.81% | -2.16 54.43% | -2.74 26.73% | -2.64 3.70% | -3.66 38.78% | -3.31 9.57% | -1.41 57.44% | -2.14 51.82% | |
operating cycle | 5.80K - | 1.79K 69.13% | 635.82 64.49% | 848.04 33.38% | ||||||
operating profit margin | -8.67 - | -2.68 69.07% | -1.87 30.20% | -0.24 87.25% | ||||||
payables turnover | 0.05 - | 0.38 632.31% | 2.87 658.40% | 3.24 12.89% | ||||||
pretax profit margin | -9.62 - | -2.86 70.29% | -2.14 25.12% | -0.38 82.13% | ||||||
price fair value | 1.33 - | 25.07 1,786.71% | 33.44 33.36% | 10.47 68.69% | 15.57 48.69% | 6.60 57.58% | 6.58 0.39% | 25.87 293.37% | -18.77 172.54% | |
receivables turnover | 8.91 - | 1.82 79.54% | 1.48 18.56% | 1.22 17.64% | ||||||
return on assets | -0.44 - | -0.30 32.41% | -0.47 56.40% | -0.40 14.61% | -0.50 25.28% | -0.82 63.22% | -0.44 45.95% | -0.46 3.28% | -0.17 61.92% | |
return on capital employed | -0.33 - | -0.33 0.81% | -0.53 61.03% | -0.42 19.95% | -0.55 29.85% | -0.90 62.91% | -0.51 43.24% | -0.52 2.96% | -0.15 71.08% | |
return on equity | -0.47 - | -1.72 269.08% | -3.96 130.75% | -0.94 76.26% | -1.07 13.80% | -1.02 4.60% | -1.20 17.10% | -7.64 539.04% | 4.32 156.50% | |
total debt to capitalization | 0.82 - | 0.87 6.38% | 0.54 37.80% | 0.48 11.56% | 0.54 - | 0.90 67.36% | 1.07 19.05% |
All numbers in (except ratios and percentages)